← Leaderboards
Jonathan R Sporn
Massachusetts General Hospital
$711,029
Attributed
$711,029
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$711,029 · 7
By mechanism
M01$711,029 · 7
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joel S Finkelstein$18,947,740
- Priscilla Kaliopi Brastianos$4,062,816
- Janet E Hall$12,273,914
- Scott Carter$2,798,679
- Douglas S Ross$602,879
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationBreast NeoplasmsFemaleSerology /SerodiagnosisBiomarkerNeoplasm /Cancer VaccineNeoplasm /Cancer ImmunotherapyTumor AntigensClinical Trial Phase ICell TransplantationB Cell LymphomaCellular ImmunityCell Mediated CytotoxicityCell LineAntineoplasticsEnzyme Linked Immunosorbent AssayClinical TrialsFibroblast Growth FactorCytotoxic T LymphocyteDiagnosis Design /EvaluationChronic Lymphocytic LeukemiaBone Neoplasms
Grant awards (38)
Herbal Therapy for Hotflashes$5,540
M01 · FY2004 · RR
PYRIDOSTIGMINE INDUCED GROWTH HORMONE RESPONSE IN MOOD DISORDERS$200,768
M01 · FY2002 · RR
PYRIDOSTIGMINE INDUCED GROWTH HORMONE RESPONSE IN MOOD DISORDERS$200,768
M01 · FY2002 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$0
M01 · FY2002 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$0
M01 · FY2002 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$0
M01 · FY2002 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$0
M01 · FY2002 · RR
PYRIDOSTIGMINE INDUCED GROWTH HORMONE RESPONSE IN MOOD DISORDERS$200,768
M01 · FY2001 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$4,361
M01 · FY2001 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$4,361
M01 · FY2001 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$4,361
M01 · FY2001 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$4,361
M01 · FY2001 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$0
M01 · FY2001 · RR
PYRIDOSTIGMINE INDUCED GROWTH HORMONE RESPONSE IN MOOD DISORDERS$0
M01 · FY2001 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$0
M01 · FY2001 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$0
M01 · FY2001 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$0
M01 · FY2001 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$0
M01 · FY2001 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$0
M01 · FY2001 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$0
M01 · FY2001 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$0
M01 · FY2001 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$19,111
M01 · FY2000 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$19,111
M01 · FY2000 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$19,111
M01 · FY2000 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$19,111
M01 · FY2000 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$4,361
M01 · FY2000 · RR
IDENTIFICATION OF TUMOR SPECIFIC T LYMPHOCYTES FROM PERIPHERAL BLOOD OF CANCER$4,361
M01 · FY2000 · RR
PYRIDOSTIGMINE INDUCED GROWTH HORMONE RESPONSE IN MOOD DISORDERS$575
M01 · FY2000 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$0
M01 · FY2000 · RR
PYRIDOSTIGMINE INDUCED GROWTH HORMONE RESPONSE IN MOOD DISORDERS$0
M01 · FY2000 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$0
M01 · FY2000 · RR
TREATMENT OF INDOLENT B CELL LYMPHOMA &CLL PATIENTS W/ HEAT SHOCK PR$0
M01 · FY2000 · RR
FIBROBLAST GROWTH FACTOR AND BONE RESORPTION IN PATIENTS WITH BREAST CANCER$0
M01 · FY2000 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$0
M01 · FY2000 · RR
MONOCYTE/HER2 VACCINE IN BREAST AND OVARIAN CANCER PATIENTS$0
M01 · FY2000 · RR
Tumor antigen &APC based breast cancer vaccine phase I/II trial$0
M01 · FY2000 · RR
Tumor antigen &APC based breast cancer vaccine phase I/II trial$0
M01 · FY2000 · RR
Tumor antigen &APC based breast cancer vaccine phase I/II trial$0
M01 · FY2000 · RR